Keywords: genzyme, 2nd-qtr, revenues, jump, usa-based, corp, posted
Genzyme's 2nd-qtr revenues jump 58%
Article | 19 July 2004
USA-based Genzyme Corp has posted a 58% leap in second-quarter 2004sales to $549.6 million versus $347.7 million for the like, year-earlier period, causing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
